We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJT icon
101
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.22B
$41.5M 0.25%
489,070
-38,302
-7% -$2.99M
BLK icon
102
Blackrock
BLK
$164B
$41.3M 0.25%
75,908
-1,283
-2% -$648K
ANET icon
103
Arista Networks
ANET
$219B
$41.2M 0.25%
3,136,176
-433,808
-12% -$5.87M
T icon
104
AT&T
T
$165B
$40.2M 0.25%
1,760,490
-690,644
-28% -$15.7M
GIS icon
105
General Mills
GIS
$19.2B
$40.1M 0.25%
650,346
-163,304
-20% -$9.85M
ATVI
106
DELISTED
Activision Blizzard
ATVI
$39.8M 0.24%
524,606
-108,995
-17% -$7.6M
TJX icon
107
TJX Companies
TJX
$170B
$38.6M 0.24%
763,026
-874,416
-53% -$43.9M
MPC icon
108
Marathon Petroleum
MPC
$90.3B
$38.3M 0.23%
1,024,295
-295,055
-22% -$9.48M
HRB icon
109
H&R Block
HRB
$5.18B
$38M 0.23%
2,662,639
+2,539,686
+2,066% +$40.1M
KO icon
110
Coca-Cola
KO
$354B
$37.4M 0.23%
837,336
+81,476
+11% +$3.75M
QCOM icon
111
Qualcomm
QCOM
$176B
$37.1M 0.23%
407,158
+2,042
+0.5% +$164K
AXP icon
112
American Express
AXP
$223B
$36.9M 0.23%
387,601
+15,638
+4% +$1.44M
SHW icon
113
Sherwin-Williams
SHW
$78.3B
$36.5M 0.22%
189,522
+5,712
+3% +$1.03M
HZNP
114
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$36.3M 0.22%
652,582
-725,010
-53% -$31M
BAC icon
115
Bank of America
BAC
$435B
$36M 0.22%
1,514,265
-316,056
-17% -$7.47M
CTSH icon
116
Cognizant
CTSH
$21.5B
$35.4M 0.22%
623,284
-94,915
-13% -$5.1M
APH icon
117
Amphenol
APH
$188B
$34.9M 0.21%
1,457,392
-2,924,940
-67% -$65.3M
RPM icon
118
RPM International
RPM
$13.7B
$34.1M 0.21%
454,277
-22,260
-5% -$1.55M
CVS icon
119
CVS Health
CVS
$137B
$33.8M 0.21%
520,156
+58,980
+13% +$3.71M
AES icon
120
AES
AES
$10.6B
$32.6M 0.2%
2,252,596
-1,110,407
-33% -$14.6M
IBM icon
121
IBM
IBM
$202B
$32.6M 0.2%
282,630
-5,862
-2% -$681K
NEM icon
122
Newmont
NEM
$98.2B
$32.5M 0.2%
525,734
-496,426
-49% -$29.4M
TXN icon
123
Texas Instruments
TXN
$255B
$32.3M 0.2%
254,193
-331,325
-57% -$38.6M
BAH icon
124
Booz Allen Hamilton
BAH
$8.7B
$32.2M 0.2%
413,586
+411,024
+16,043% +$31.1M
C icon
125
Citigroup
C
$222B
$31.9M 0.19%
623,359
-137,930
-18% -$6.54M

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.